NO20044581L - Anvendelse av soppen Agaricus blazei Murill ved fremstilling av medikamenter til bekjempelse av infeksjoner og allergier - Google Patents

Anvendelse av soppen Agaricus blazei Murill ved fremstilling av medikamenter til bekjempelse av infeksjoner og allergier

Info

Publication number
NO20044581L
NO20044581L NO20044581A NO20044581A NO20044581L NO 20044581 L NO20044581 L NO 20044581L NO 20044581 A NO20044581 A NO 20044581A NO 20044581 A NO20044581 A NO 20044581A NO 20044581 L NO20044581 L NO 20044581L
Authority
NO
Norway
Prior art keywords
manufacture
allergies
medications
agaricus blazei
blazei murill
Prior art date
Application number
NO20044581A
Other languages
English (en)
Other versions
NO20044581D0 (no
Inventor
Geir Hetland
Original Assignee
Geir Hetland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geir Hetland filed Critical Geir Hetland
Priority to NO20044581A priority Critical patent/NO20044581L/no
Publication of NO20044581D0 publication Critical patent/NO20044581D0/no
Priority to RU2006129301/15A priority patent/RU2006129301A/ru
Priority to PCT/NO2005/000012 priority patent/WO2005065063A2/en
Priority to JP2006549171A priority patent/JP2007517867A/ja
Priority to US10/585,600 priority patent/US20080233144A1/en
Priority to EP05704631A priority patent/EP1708673A2/en
Publication of NO20044581L publication Critical patent/NO20044581L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/071—Agaricus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse vedrører anvendelse av soppen Agaricus blazei murill (AbM) ved fremstilling av et medikament til bekjempelse eller forebygning av bakterielle og ikke-bakterielle infeksjoner (for eksempel parasitter eller virus) i pattedyr samt til bekjempelse og forebygging av allergi hos pattedyr. Eksempelvis kan en slik infeksjon være forårsaket av pneumokokker og enda mer spesielt hvor pattedyret er et menneske.
NO20044581A 2004-01-12 2004-10-25 Anvendelse av soppen Agaricus blazei Murill ved fremstilling av medikamenter til bekjempelse av infeksjoner og allergier NO20044581L (no)

Priority Applications (6)

Application Number Priority Date Filing Date Title
NO20044581A NO20044581L (no) 2004-01-12 2004-10-25 Anvendelse av soppen Agaricus blazei Murill ved fremstilling av medikamenter til bekjempelse av infeksjoner og allergier
RU2006129301/15A RU2006129301A (ru) 2004-01-12 2005-01-10 Применение agaricus blazei для получения лекарственных средств, пригодных для лечения инфекций и аллергий
PCT/NO2005/000012 WO2005065063A2 (en) 2004-01-12 2005-01-10 Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies
JP2006549171A JP2007517867A (ja) 2004-01-12 2005-01-10 感染症およびアレルギー治療用医薬品製造におけるキノコＡｇａｒｉｃｕｓＢｌａｚｅｉＭｕｒｉｌｌの使用
US10/585,600 US20080233144A1 (en) 2004-01-12 2005-01-10 Use of the Mushroom Agaricus Blazei Murill for the Production of Medicaments Suitable for Treating Infections and Allergies
EP05704631A EP1708673A2 (en) 2004-01-12 2005-01-10 Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20040128 2004-01-12
NO20044581A NO20044581L (no) 2004-01-12 2004-10-25 Anvendelse av soppen Agaricus blazei Murill ved fremstilling av medikamenter til bekjempelse av infeksjoner og allergier

Publications (2)

Publication Number Publication Date
NO20044581D0 NO20044581D0 (no) 2004-10-25
NO20044581L true NO20044581L (no) 2005-07-13

Family

ID=34752278

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044581A NO20044581L (no) 2004-01-12 2004-10-25 Anvendelse av soppen Agaricus blazei Murill ved fremstilling av medikamenter til bekjempelse av infeksjoner og allergier

Country Status (6)

Country Link
US (1) US20080233144A1 (no)
EP (1) EP1708673A2 (no)
JP (1) JP2007517867A (no)
NO (1) NO20044581L (no)
RU (1) RU2006129301A (no)
WO (1) WO2005065063A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5747205B2 (ja) * 2010-02-19 2015-07-08 ビーエイチエヌ株式会社 抗インフルエンザ剤
BRPI1002067A8 (pt) * 2010-05-11 2017-10-31 Coop Dos Produtores De Cogumelos Da Regiao Metropolitana De Belohorizonte – Minasfungi Do Brasil Formulação leishmanicida e seu uso

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01228480A (ja) * 1988-03-09 1989-09-12 Nippon Hai Potsukusu:Kk 食用担子菌菌糸体培養抽出物の製造方法
JPH11263732A (ja) * 1998-03-16 1999-09-28 Ichimaru Pharcos Co Ltd キノコ類抽出物含有皮膚外用剤
JPH11279204A (ja) * 1998-03-27 1999-10-12 Sumitomo Forestry Co Ltd 免疫抑制剤
JP2000032946A (ja) * 1998-07-22 2000-02-02 Pawafuru Kenko Shokuhin Kk 機能性食品
JP2004501096A (ja) * 2000-05-09 2004-01-15 有限会社筑波バイオシステム ヒアルロニダーゼ活性及びアレルギー誘引細胞活性抑制剤
JP4499979B2 (ja) * 2001-05-21 2010-07-14 コンビ株式会社 病原菌感染抑制用組成物
NO20014256D0 (no) * 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
KR20030021096A (ko) * 2001-09-05 2003-03-12 김응섭 아가리쿠스버섯과 죽염을 이용한 아가리쿠스 죽염의제조방법.

Also Published As

Publication number Publication date
RU2006129301A (ru) 2008-02-20
WO2005065063A3 (en) 2005-11-17
JP2007517867A (ja) 2007-07-05
EP1708673A2 (en) 2006-10-11
NO20044581D0 (no) 2004-10-25
US20080233144A1 (en) 2008-09-25
WO2005065063A2 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
Whibley et al. Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species
EP4112648A4 (en) PROTEIN AND VACCINE AGAINST SARS-COV-2 INFECTION
NO20073900L (no) Anvendelse av LGG for fremstilling av et medikament for forebygging eller behandling av respiratoriske sykdommer
WO2010036945A3 (en) Nanoemulsion therapeutic compositions and methods of using the same
NO20070988L (no) Vaksine for forebygging og behandling av HIV-infeksjon
CL2022003491A1 (es) Moléculas de anticuerpo contra el virus bk
DE602007013618D1 (de) Antikörper gegen das humane cytomegalie-virus (hcmv)
WO2010034670A3 (en) Host cell kinases as targets for antiviral therapies against hcv infection
ATE476983T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege
WO2008118849A3 (en) Hiv-1 protease inhibitors
WO2009023306A3 (en) Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
EA200970529A1 (ru) Антивирусная композиция и способ ее применения
GB2453491A (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
PE20081215A1 (es) Identificacion y caracterizacion de variantes de replicon de vhc con menor susceptibilidad a vhc-796, y metodos relacionados
EA201300132A1 (ru) Фармацевтическая композиция и методы лечения и профилактики заболеваний, вызванных вич или ассоциированных с вич
WO2015058772A3 (en) Novel hcv culture systems and direct-acting antiviral sensitivity
BR112022000971A2 (pt) Derivados de di-hidropirimidina e uso dos mesmos no tratamento de infecção por hbv ou de doenças induzidas por hbv
WO2016086153A3 (en) Use of hsp90 inhibitors for the treatment of hiv infections and aids
EA201300136A1 (ru) Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
EA201290689A1 (ru) Лечение стрептококковых инфекций
BRPI0706871A2 (pt) uso de um extrato de sambucus nigra l., método de tratamento de uma infecção viral de influenza e método de inibição da infecção viral de influenza
CL2007002710A1 (es) Formulacion inmunogenica que confiere proteccion contra la infeccion o patologia causada por el virus respiratorio sincicial (vrs) que comprende una cepa recombinante atenuada de mycobacterium; y uso de la formulacion inmunogenica para preparar una vacuna para prevenir, tratar o atenuar infecciones del vrs.
WO2010138419A3 (en) Materials and methods for treating viral infections
WO2009005040A1 (ja) 緑膿菌の外膜タンパク質pa4710
NO20044581L (no) Anvendelse av soppen Agaricus blazei Murill ved fremstilling av medikamenter til bekjempelse av infeksjoner og allergier

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application